【ChiCTR2500099134】Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
ChiCTR2500099134
尚未开始
/
/
/
2025-03-19
/
/
Nil
Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
The objectives of this research are to evaluate the effect of the evidence-based assessment instrument to minimize the use of PR in general adult ward settings, and the process evaluation and satisfaction of the evidence-based assessment instrument when applying in general adult ward settings in Hong Kong.
整群随机分组
其它
A single blinded cluster randomized controlled trial will be conducted in a total of eight wards within the department of Medicine & Geriatrics (M&G), the department of Orthopaedics & Traumatology (O&T), and the Department of Surgery (SUR) from 8th April to 9th June 2025 at UCH. Two wards from O&T and SUR, along with four wards from M&G, will be randomly assigned using simple random sampling.
A single blinded cluster randomized controlled trial will be conducted as the patient does not know which group they are allocated.
Nil
/
932
/
2025-03-25
2025-06-09
/
Participants aged 18 or above and admitted to the general adult ward settings at the research sites within the hospital are eligible to participate in the study. All nurses who provide direct patient care, will be included for the process evaluation and satisfaction review.；
请登录查看For the clinical study, there are no exclusion criteria, as all patients are under treatment and care during hospitalization. Participation in the evaluation is voluntary for healthcare providers who wish to give feedback and participate in the survey.；
请登录查看United Christian Hospital, Hong Kong Hospital Authority
/
United Christian Hospital, Hong Kong Hospital Authority的其他临床试验
United Christian Hospital, Hong Kong Hospital Authority的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10